GCDx is apparently still trying to sell DR-70 with no scientific white paper to explain what the test even IS, no FDA clearance, and no proof it works. I think it's only a matter of time before the FDA catches up to them. The FDA recently caught up to Pathway Genomics for doing basically the same thing: selling a blood test as a cancer screener without getting FDA clearance and without providing proof that it works:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.